PULMICORT NEBUAMP 0.25 MG/ML

Google image searchProduct monograph

Active ingredient

budesonide, 0.25 MG/ML

DIN: 01978918

Dosage form(s): SUSPENSION

Route(s) of administration: INHALATION

Schedule: Prescription

Company: ASTRAZENECA CANADA INC

Date: 29-JAN-2000

ATC:

• R03 — DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES (ATC, ATC/DDD, )
• R03B — OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS (ATC, ATC/DDD)
• R03BA — Glucocorticoids (ATC, ATC/DDD)
• R03BA02 — BUDESONIDE (ATC/DDD)

Reference brand drug: Rhinocort

Pharmaceutical standard: MFR

External Links for Pulmicort Nebuamp 0.25 Mg/Ml

Search on Google

• Pulmicort Nebuamp 0.25 Mg/Ml side effects
• Pulmicort Nebuamp 0.25 Mg/Ml dosage
• budesonide side effects
• budesonide dosage

Astrazeneca Canada Inc

Go to AstraZeneca website to see drug product details. Sometimes you can find pulmicort nebuamp 0.25 mg/ml photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.